BIOTRONIK Wins FDA Approval for Two High-Voltage Families of Cardiac Implants

The FDA has given BIOTRONIK approval to introduce the company’s Acticor and Rivacor lines of high-voltage cardiac rhythm implants. They’re designed to treat tachycardia (likely supraventricular tachycardia (SVT) and have been made to be s...

Source: Medgadget - March 15, 2019 Category: Medical Devices Authors: Editors Tags: Cardiology Source Type: blogs